Pliant Therapeutics
PLRX
PLRX
143 hedge funds and large institutions have $1.5B invested in Pliant Therapeutics in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 57 increasing their positions, 30 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% more funds holding
Funds holding: 125 → 143 (+18)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
3.73% more ownership
Funds ownership: 91.68% → 95.41% (+3.7%)
Holders
143
Holding in Top 10
10
Calls
$11.8M
Puts
$9.61M
Top Buyers
| 1 | +$46.9M | |
| 2 | +$44.9M | |
| 3 | +$28.1M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$26.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$24M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$13.5M | |
| 3 | -$7.48M | |
| 4 |
CA
CHI Advisors
New York
|
-$4.47M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$3.13M |